News & Events - Sep 16th, 2021
4P-Pharma joins forces with Qingdao Marine Biomedical Research Institute for translation research in China and Europe
4P-Pharma and Qingdao Marine Biomedical Research Institute (QMBRI) have decided to combine their expertise to jointly develop their first-in-class drug candidates in China and Europe through the signature of a Memorandum of Understanding (MoU) to deal with their respective molecules. “[…] It is our ambition to create a fruitful and long-term partnership for our&hellip